| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:734121 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CITED2 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:620112 | 6480464 | Ethinyl Estradiol results in decreased expression of CITED2 mRNA | CTD | PMID:17351261 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CITED2 mRNA | CTD | PMID:19619570 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CITED2 mRNA | CTD | PMID:19619570 more ... |
| 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of CITED2 mRNA | CTD | PMID:22574217 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CITED2 mRNA | CTD | PMID:19619570 more ... |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CITED2 mRNA | CTD | PMID:11331657 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of CITED2 mRNA | CTD | PMID:17404688 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CITED2 mRNA | CTD | PMID:19619570 PMID:20106945 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | RGD:620112 | 6480464 | [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of CITED2 mRNA | CTD | PMID:16984957 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CITED2 mRNA | CTD | PMID:19619570 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:620112 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CITED2 mRNA | CTD | PMID:16054898 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:734121 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CITED2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:620112 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CITED2 mRNA | CTD | PMID:16054898 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:620112 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CITED2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:620112 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CITED2 mRNA | CTD | PMID:16054898 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:620112 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CITED2 mRNA | CTD | PMID:18796159 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:620112 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CITED2 mRNA | CTD | PMID:16054898 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:620112 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CITED2 mRNA | CTD | PMID:18796159 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:620112 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CITED2 mRNA | CTD | PMID:18796159 PMID:16054898 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:734121 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CITED2 mRNA | CTD | PMID:14728982 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:734121 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CITED2 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:734121 | 6480464 | AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CITED2 mRNA] | CTD | PMID:14728982 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CITED2 mRNA | CTD | PMID:19619570 PMID:19684285 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Cycloheximide] affects the expression of CITED2 mRNA | CTD | PMID:19684285 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:620112 | 6480464 | 2,4-dinitrotoluene affects the expression of CITED2 mRNA | CTD | PMID:21346803 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | ISO | RGD:620112 | 6480464 | [3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in decreased expression of CITED2 mRNA | CTD | PMID:16984957 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | RGD:620112 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CITED2 mRNA | CTD | PMID:19692669 PMID:20959002 |
| 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | RGD:620112 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of CITED2 mRNA | CTD | PMID:19692669 |
| 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:620112 | 6480464 | 1,2-dithiol-3-thione results in decreased expression of CITED2 mRNA | CTD | PMID:19162173 |
| 4-phenylbutyric acid | decreases expression | EXP | | 6480464 | 4-phenylbutyric acid results in decreased expression of CITED2 mRNA | CTD | PMID:14583596 |
| 5-fluorouracil | affects response to substance | EXP | | 6480464 | CITED2 protein affects the susceptibility to Fluorouracil | CTD | PMID:15548681 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CITED2 mRNA | CTD | PMID:17138961 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:620112 | 6480464 | Tretinoin results in decreased expression of CITED2 mRNA | CTD | PMID:20488242 |
| all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CITED2 mRNA | CTD | PMID:21934132 |
| ammonium chloride | affects expression | ISO | RGD:620112 | 6480464 | Ammonium Chloride affects the expression of CITED2 mRNA | CTD | PMID:16483693 |
| benzene | multiple interactions | ISO | RGD:620112 | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of CITED2 mRNA | CTD | PMID:17905399 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CITED2 mRNA | CTD | PMID:17879257 |
| benzo[a]pyrene | decreases expression | ISO | RGD:734121 | 6480464 | Benzo(a)pyrene results in decreased expression of CITED2 mRNA | CTD | PMID:19770486 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CITED2 mRNA | CTD | PMID:11331657 |
| C60 fullerene | increases expression | ISO | RGD:620112 | 6480464 | fullerene C60 results in increased expression of CITED2 mRNA | CTD | PMID:19167457 |
| cadmium dichloride | increases methylation | ISO | RGD:620112 | 6480464 | Cadmium Chloride results in increased methylation of CITED2 promoter | CTD | PMID:22457795 |
| calcium atom | affects expression | ISO | RGD:620112 | 6480464 | Calcium affects the expression of CITED2 mRNA | CTD | PMID:15913539 |
| calcium(0) | affects expression | ISO | RGD:620112 | 6480464 | Calcium affects the expression of CITED2 mRNA | CTD | PMID:15913539 |
| carboplatin | increases expression | ISO | RGD:620112 | 6480464 | Carboplatin results in increased expression of CITED2 mRNA | CTD | PMID:18172885 |
| cefaloridine | increases expression | ISO | RGD:620112 | 6480464 | Cephaloridine results in increased expression of CITED2 mRNA | CTD | PMID:18172885 |
| celastrol | decreases expression | EXP | | 6480464 | tripterine results in decreased expression of CITED2 mRNA | CTD | PMID:17010675 |
| chlorpromazine | decreases expression | ISO | RGD:620112 | 6480464 | Chlorpromazine results in decreased expression of CITED2 mRNA | CTD | PMID:18246545 |
| ciglitazone | multiple interactions | EXP | | 6480464 | [ciglitazone binds to PPARG protein] which results in increased expression of CITED2 mRNA | CTD | PMID:16197558 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of CITED2 mRNA; more ... | CTD | PMID:21660965 |
| cisplatin | increases expression | ISO | RGD:620112 | 6480464 | Cisplatin results in increased expression of CITED2 mRNA | CTD | PMID:18172885 |
| cisplatin | decreases response to substance | EXP | | 6480464 | CITED2 results in decreased susceptibility to Cisplatin | CTD | PMID:21660965 |
| cisplatin | multiple interactions | EXP | | 6480464 | CITED2 mutant form promotes the reaction [Cisplatin results in increased cleavage of CASP3 protein]; more ... | CTD | PMID:21660965 |
| clofibrate | decreases expression | ISO | RGD:620112 | 6480464 | Clofibrate results in decreased expression of CITED2 mRNA | CTD | PMID:18246545 |
| cobalt dichloride | multiple interactions | EXP | | 6480464 | zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CITED2 mRNA] | CTD | PMID:22202117 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of CITED2 mRNA | CTD | PMID:19376846 PMID:22202117 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of CITED2 mRNA | CTD | PMID:22202117 PMID:19376846 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of CITED2 mRNA | CTD | PMID:22202117 |
| copper(2+) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of CITED2 mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CITED2 mRNA | CTD | PMID:19167446 |
| crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos, Crocidolite results in increased expression of CITED2 mRNA | CTD | PMID:18687144 |
| cycloheximide | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Cycloheximide] affects the expression of CITED2 mRNA | CTD | PMID:19684285 |
| cyclophosphamide | affects expression | ISO | RGD:620112 | 6480464 | Cyclophosphamide affects the expression of CITED2 mRNA | CTD | PMID:18246545 |
| cyclophosphamide | decreases expression | ISO | RGD:620112 | 6480464 | Cyclophosphamide results in decreased expression of CITED2 mRNA | CTD | PMID:18246545 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CITED2 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CITED2 mRNA | CTD | PMID:20106945 PMID:21632981 |
| cyclosporin A | increases expression | ISO | RGD:620112 | 6480464 | Cyclosporine results in increased expression of CITED2 mRNA | CTD | PMID:18172885 |
| cytarabine | decreases expression | EXP | | 6480464 | Cytarabine results in decreased expression of CITED2 mRNA | CTD | PMID:21198554 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:734121 | 6480464 | Tetrahydrocannabinol results in increased expression of CITED2 protein; more ... | CTD | PMID:12237329 |
| dexamethasone | multiple interactions | ISO | RGD:734121 | 6480464 | CITED2 protein inhibits the reaction [Dexamethasone results in increased expression of FBXO32 mRNA]; more ... | CTD | PMID:19032942 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of CITED2 mRNA | CTD | PMID:15725085 |
| diazoxide | increases expression | ISO | RGD:734121 | 6480464 | Isoproterenol results in increased expression of CITED2 mRNA | CTD | PMID:20003209 |
| dibutyl phthalate | increases expression | ISO | RGD:620112 | 6480464 | Dibutyl Phthalate results in increased expression of CITED2 mRNA | CTD | PMID:21266533 |
| diethyl maleate | decreases expression | ISO | RGD:620112 | 6480464 | diethyl maleate results in decreased expression of CITED2 mRNA | CTD | PMID:21161181 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of CITED2 mRNA | CTD | PMID:11331657 |
| diuron | decreases expression | ISO | RGD:620112 | 6480464 | Diuron results in decreased expression of CITED2 mRNA | CTD | PMID:21551480 |
| doxorubicin | decreases response to substance | EXP | | 6480464 | CITED2 results in decreased susceptibility to Doxorubicin | CTD | PMID:21660965 |
| doxorubicin | increases expression | ISO | RGD:620112 | 6480464 | Doxorubicin results in increased expression of CITED2 mRNA | CTD | PMID:19915844 |
| ethanol | increases expression | ISO | RGD:620112 | 6480464 | Ethanol results in increased expression of CITED2 mRNA | CTD | PMID:16098508 |
| flurbiprofen | increases expression | ISO | RGD:734121 | 6480464 | Flurbiprofen results in increased expression of CITED2 mRNA | CTD | PMID:16949054 |
| formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of CITED2 mRNA | CTD | PMID:20655997 |
| gamma-hexachlorocyclohexane | increases expression | ISO | RGD:620112 | 6480464 | Lindane results in increased expression of CITED2 mRNA | CTD | PMID:17785943 |
| gedunin | decreases expression | EXP | | 6480464 | gedunin results in decreased expression of CITED2 mRNA | CTD | PMID:17010675 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of CITED2 mRNA | CTD | PMID:11331657 |
| hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of CITED2 mRNA | CTD | PMID:20044591 |
| indomethacin | decreases expression | EXP | | 6480464 | Indomethacin results in decreased expression of CITED2 mRNA | CTD | PMID:16984733 |
| isoprenaline | increases expression | ISO | RGD:734121 | 6480464 | Isoproterenol results in increased expression of CITED2 mRNA | CTD | PMID:20003209 |
| kainic acid | increases expression | ISO | RGD:620112 | 6480464 | Kainic Acid results in increased expression of CITED2 mRNA | CTD | PMID:19700661 |
| menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of CITED2 mRNA | CTD | PMID:20044591 |
| methylmercury(1+) | multiple interactions | ISO | RGD:620112 | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of CITED2 mRNA | CTD | PMID:17905399 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:734121 | 6480464 | Diethylnitrosamine results in increased expression of CITED2 mRNA | CTD | PMID:18691550 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:620112 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of CITED2 mRNA | CTD | PMID:18164116 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:734121 | 6480464 | MAPK14 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CITED2 mRNA] | CTD | PMID:18691550 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of CITED2 mRNA | CTD | PMID:21455298 |
| nickel sulfate | decreases expression | EXP | | 6480464 | nickel sulfate results in decreased expression of CITED2 mRNA | CTD | PMID:18651567 |
| paracetamol | affects expression | ISO | RGD:734121 | 6480464 | Acetaminophen affects the expression of CITED2 mRNA | CTD | PMID:17562736 |
| perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:620112 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of CITED2 mRNA | CTD | PMID:18692542 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:620112 | 6480464 | perfluorooctanoic acid results in decreased expression of CITED2 mRNA | CTD | PMID:19162173 |
| phenobarbital | increases expression | ISO | RGD:734121 | 6480464 | Phenobarbital results in increased expression of CITED2 mRNA | CTD | PMID:19270015 |
| phenobarbital | decreases expression | ISO | RGD:620112 | 6480464 | Phenobarbital results in decreased expression of CITED2 mRNA | CTD | PMID:19162173 |
| pirinixic acid | multiple interactions | ISO | RGD:734121 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CITED2 mRNA | CTD | PMID:19710929 |
| pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:620112 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of CITED2 mRNA | CTD | PMID:19162173 |
| progesterone | multiple interactions | EXP | | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of CITED2 mRNA | CTD | PMID:17404688 |
| progesterone | multiple interactions | ISO | RGD:734121 | 6480464 | [Progesterone results in increased activity of PGR protein] which results in increased expression of CITED2 mRNA | CTD | PMID:15845616 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of CITED2 mRNA | CTD | PMID:21632981 |
| rosiglitazone | decreases expression | ISO | RGD:620112 | 6480464 | rosiglitazone results in decreased expression of CITED2 mRNA | CTD | PMID:21515302 |
| streptozocin | increases expression | ISO | RGD:620112 | 6480464 | Streptozocin results in increased expression of CITED2 mRNA | CTD | PMID:16684804 |
| streptozocin | multiple interactions | ISO | RGD:620112 | 6480464 | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of CITED2 mRNA] | CTD | PMID:16684804 |
| tamoxifen | increases response to substance | EXP | | 6480464 | CITED2 mRNA results in increased susceptibility to Tamoxifen | CTD | PMID:19904269 |
| tamoxifen | affects expression | ISO | RGD:734121 | 6480464 | Tamoxifen affects the expression of CITED2 mRNA | CTD | PMID:20937368 |
| thimerosal | increases expression | EXP | | 6480464 | Thimerosal results in increased expression of CITED2 mRNA | CTD | PMID:16870260 |
| topiramate | decreases expression | ISO | RGD:620112 | 6480464 | topiramate results in decreased expression of CITED2 mRNA | CTD | PMID:16979414 |
| topotecan | affects response to substance | EXP | | 6480464 | CITED2 protein affects the susceptibility to Topotecan | CTD | PMID:16217747 |
| trichloroethene | multiple interactions | ISO | RGD:620112 | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of CITED2 mRNA | CTD | PMID:17905399 |
| troglitazone | decreases expression | ISO | RGD:620112 | 6480464 | troglitazone results in decreased expression of CITED2 mRNA | CTD | PMID:21515302 |
| ursodeoxycholic acid | decreases expression | ISO | RGD:620112 | 6480464 | Ursodeoxycholic Acid results in decreased expression of CITED2 mRNA | CTD | PMID:15885361 |
| valproic acid | affects expression | ISO | RGD:734121 | 6480464 | Valproic Acid affects the expression of CITED2 mRNA | CTD | PMID:17292431 |
| vanadyl sulfate | multiple interactions | ISO | RGD:620112 | 6480464 | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of CITED2 mRNA] | CTD | PMID:16684804 |
| zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of CITED2 mRNA | CTD | PMID:18593933 |
| zinc dichloride | multiple interactions | EXP | | 6480464 | zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CITED2 mRNA] | CTD | PMID:22202117 |
| zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of CITED2 mRNA | CTD | PMID:18593933 |